160
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Platinum Combination Chemotherapy Is Poorly Tolerated in Malnourished Advanced Lung Cancer Patients with Poor Performance Status

, , ORCID Icon, , , , , , & show all
Pages 767-771 | Received 31 Jul 2018, Accepted 26 Nov 2018, Published online: 26 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tateaki Naito. (2019) Emerging Treatment Options For Cancer-Associated Cachexia: A Literature Review. Therapeutics and Clinical Risk Management 15, pages 1253-1266.
Read now

Articles from other publishers (4)

Satoshi Ikeda, Tateaki Naito, Satoru Miura, Kentaro Ito, Naoki Furuya, Toshihiro Misumi, Takashi Ogura & Terufumi Kato. (2022) Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?. Cancers 14:19, pages 4861.
Crossref
Taichi Miyawaki, Tateaki Naito, Michitoshi Yabe, Hiroaki Kodama, Naoya Nishioka, Eriko Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Haruyasu Murakami, Keita Mori, Hideyuki Harada, Kazuhisa Takahashi & Toshiaki Takahashi. (2021) Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer. Supportive Care in Cancer 30:2, pages 1633-1641.
Crossref
Johan Isaksson, Leo Wennström, Eva Branden, Hirsh Koyi, Anders Berglund, Patrick Micke, Johanna Sofia Margareta Mattsson, Linda Willén & Johan Botling. (2022) Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer. Cancer Treatment and Research Communications 31, pages 100556.
Crossref
Kazuhisa Nakashima, Kojiro Hata, Takamasa Hotta, Seiko Tanaka, Yuki Mitarai, Takae Okuno, Akari Tanino, Mika Nakao, Yoshihiro Amano, Megumi Hamaguchi, Tamio Okimoto, Shunichi Hamaguchi, Taishi Nagao, Noriaki Kurimoto, Takeshi Isobe & Yukari Tsubata. (2021) Ability of the Glasgow Prognostic Score to predict the tolerability and efficacy of platinum-combination chemotherapy among elderly patients with advanced non-small cell lung cancer. The Journal of Medical Investigation 68:3.4, pages 260-264.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.